Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -44.00M
June 30, 2026 -76.00M
March 31, 2026 386.00M
December 31, 2025 -65.00M
September 30, 2025 -115.00M
June 30, 2025 -38.00M
March 31, 2025 -172.00M
December 31, 2024 -296.00M
September 30, 2024 -75.00M
June 30, 2024 -46.00M
March 31, 2024 -96.00M
December 31, 2023 -81.00M
September 30, 2023 -55.00M
June 30, 2023 -70.00M
Date Value
March 31, 2023 -54.00M
December 31, 2022 -61.00M
September 30, 2022 -213.00M
June 30, 2022 -83.00M
March 31, 2022 -63.00M
December 31, 2021 -133.00M
September 30, 2021 -61.00M
June 30, 2021 -249.00M
March 31, 2021 -38.00M
December 31, 2020 -127.00M
September 30, 2020 -41.00M
June 30, 2020 -41.00M
March 31, 2020 -49.00M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 292.30M
Pacira Biosciences, Inc. 60.81M
ANI Pharmaceuticals, Inc. -13.50M
Corcept Therapeutics, Inc. -131.99M
Veru, Inc. 1.802M